SCHEMBL7477987

SCHEMBL7477987

Cc1[nH]c2ccc(NS(C)(=O)=O)cc2c1C1CCN(C)CC1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.45
HTR1D P28221 3/20 0.44
HTR1B P28222 3/20 0.44
HTR1F P30939 2/20 0.44
HTR2A P28223 1/20 0.43
OPRM1 P35372 3/20 0.43
OPRK1 P41145 3/20 0.43
OPRD1 P41143 2/20 0.43
OPRL1 P41146 2/20 0.43
HTR1A P08908 1/20 0.42
APP P05067 1/20 0.41
MCHR1 Q99705 1/20 0.41
CCNT1 O60563 1/20 0.40
CDK9 P50750 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5372600 0.77 CYP1A2 (0.58) HTR6HTR1DHTR2AOPRM1OPRK1
Hydrochloric Acid SCHEMBL5372543 0.76 CYP1A2 (0.56) HTR6HTR1DHTR2AOPRM1OPRK1
SCHEMBL7487112 0.75 OPRM1 (0.43) OPRM1OPRK1OPRD1OPRL1MCHR1
Oxalic Acid SCHEMBL7487604 0.74 HTR1D (0.68) HTR6HTR1DHTR1BHTR1FHTR1A
Hydrochloric Acid SCHEMBL5375438 0.74 MCHR1 (0.52) HTR6HTR2AOPRM1OPRK1OPRD1
SCHEMBL5373938 0.73 HTR2A (0.46) HTR6HTR1DHTR1FHTR2AOPRM1
SCHEMBL7483279 0.71 HTR6 (0.65) HTR6HTR1ACCNT1CDK9
SCHEMBL5375353 0.71 HTR6 (0.59) HTR6HTR2AOPRM1OPRK1OPRD1
Hydrochloric Acid SCHEMBL8550201 0.71 DRD2 (0.48) HTR6HTR1DHTR1BHTR1FHTR2A
SCHEMBL6646899 0.69 HTR6 (0.47) HTR6HTR2AOPRM1OPRK1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0733628-B9 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2002-06-12 EP disclosed
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0733628-B1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1H-indoles: 5-HT1F agonists LILLY CO ELI (US) 2000-12-27 EP disclosed
CN-1233180-A Treatment of the common cold or allergic rhinitis LILLY CO ELI (US) 1999-10-27 CN disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5962474-A ANALGESICS; HEADACHES ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
CN-1184425-A 5-substituted-3- (1,2,3, 6-tetrahydropyridin-4-yl) -and 3- (piperidin-4-yl) -1H-indoles, 5-HT1FAgonists LILLY CO ELI (US) 1998-06-10 CN disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
WO-1998011895-A1 A METHOD FOR THE PREVENTION OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-03-26 WO disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708008-A TREATMENT OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
WO-1996029075-A1 5-SUBSTITUTED-3-(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)- AND 3-(PIPERIDIN-4-YL)-1H-INDOLES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1996-09-26 WO disclosed
EP-0733628-A1 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists ELI LILLY AND COMPANY (US) 1996-09-25 EP disclosed